Could Dyadic (DYAI) $5.75 Provide a Solution to Help Mass Produce Vaccines to Battle Viruses Like the CoronaVirus?

Dyadic

Dyadic (DYAI) has developed a biomanufacturing technology platform, nicknamed C1 which helps to speed the development, lower the manufacturing cost and potentially improve the performance of biologic vaccines & drugs including vaccines against Zoonotic diseases.

READ MORE HERE:

Dyadic is in our Biotech 5 Pack. 5 Biotech Stocks We Expect to Double in 2020.

LIVE CHART

See applicable disclosure and disclaimer details on ALL reports.